Open Access
The third universal definition of myocardial infarction
Reads0
Chats0
TLDR
This article aims to provide a summary of this document along with its implications for nursing practice in different clinical situations.Abstract:
different clinical situations. This article aims to provide a summary of this document along with its implications for nursing practice. The third universal definition of myocardial infarction The main feature of this new definition is the recognition of a rise and/or fall of cardiac biomarker values, with at least one of the values being raised. The favoured cardiac biomarker of myocardial injury is the highly sensitive and specific cardiac troponin (cTn). At least one of the following criteria should also be met: w Symptoms of ischaemia w New significant ST/T wave changes or left bundle-branch block w Appearance of pathological Q waves on an electrocardiogram (ECG) w Evidence of recent loss of viable myocardium or regional wall motion abnormalityread more
Citations
More filters
Journal ArticleDOI
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
Gregory A. Roth,Catherine O. Johnson,Amanuel Alemu Abajobir,Foad Abd-Allah,Semaw Ferede Abera,Gebre Yitayih Abyu,Muktar Beshir Ahmed,Baran Aksut,Tahiya Alam,Khurshid Alam,François Alla,Nelson Alvis-Guzman,Stephen M. Amrock,Hossein Ansari,Johan Ärnlöv,Hamid Asayesh,Tesfay Mehari Atey,Leticia Avila-Burgos,Ashish Awasthi,Amitava Banerjee,Aleksandra Barac,Till Bärnighausen,Lars Barregard,Neeraj Bedi,Ezra Belay Ketema,Derrick A Bennett,Gebremedhin Berhe,Zulfiqar A Bhutta,Shimelash Bitew,Jonathan R. Carapetis,Juan Jesus Carrero,Deborah Carvalho Malta,Carlos A Castañeda-Orjuela,Jacqueline Castillo-Rivas,Ferrán Catalá-López,Jee Young Choi,Hanne Christensen,Massimo Cirillo,Leslie T. Cooper,Michael H. Criqui,David K. Cundiff,Albertino Damasceno,Lalit Dandona,Lalit Dandona,Rakhi Dandona,Rakhi Dandona,Kairat Davletov,Samath D Dharmaratne,Prabhakaran Dorairaj,Manisha Dubey,Rebecca Ehrenkranz,Maysaa El Sayed Zaki,Emerito Jose Aquino Faraon,Alireza Esteghamati,Talha Farid,Maryam S. Farvid,Valery L. Feigin,Eric L. Ding,Gerry Fowkes,Tsegaye Tewelde Gebrehiwot,Richard F. Gillum,Audra Gold,Philimon Gona,Rajeev Gupta,Tesfa Dejenie Habtewold,Nima Hafezi-Nejad,Tesfaye Hailu,Gessessew Bugssa Hailu,Graeme J. Hankey,Hamid Yimam Hassen,Kalkidan Hassen Abate,Rasmus Havmoeller,Simon I. Hay,Simon I. Hay,Masako Horino,Peter J. Hotez,Kathryn H. Jacobsen,Spencer L. James,Mehdi Javanbakht,Panniyammakal Jeemon,Denny John,Jost B. Jonas,Yogeshwar Kalkonde,Chante Karimkhani,Amir Kasaeian,Yousef Khader,Abdur Rahman Khan,Young-Ho Khang,Sahil Khera,Abdullah T Khoja,Jagdish Khubchandani,Daniel Kim,Dhaval Kolte,Soewarta Kosen,Kristopher J Krohn,G Anil Kumar,Gene F. Kwan,Dharmesh Kumar Lal,Anders Larsson,Shai Linn,Alan D. Lopez,Paulo A. Lotufo,Hassan Magdy Abd El Razek,Reza Malekzadeh,Mohsen Mazidi,Toni Meier,Kidanu Gebremariam Meles,George A. Mensah,Atte Meretoja,Haftay Berhane Mezgebe,Ted R. Miller,Erkin M. Mirrakhimov,Shafiu Mohammed,Andrew E. Moran,Kamarul Imran Musa,Jagat Narula,Bruce Neal,Frida Namnyak Ngalesoni,Grant Nguyen,Carla Makhlouf Obermeyer,Mayowa O. Owolabi,George C Patton,João Mário Pedro,Dima M. Qato,Mostafa Qorbani,Kazem Rahimi,Rajesh Kumar Rai,Salman Rawaf,Antonio Luiz Pinho Ribeiro,Saeid Safiri,Joshua A. Salomon,Itamar S. Santos,Milena M Santric Milicevic,Benn Sartorius,Aletta E. Schutte,Sadaf G. Sepanlou,Masood Ali Shaikh,Min-Jeong Shin,Mehdi H. Shishehbor,Hirbo Shore,Diego Augusto Santos Silva,Eugene Sobngwi,Saverio Stranges,Soumya Swaminathan,Rafael Tabarés-Seisdedos,Niguse Tadele Atnafu,Fisaha Haile Tesfay,Jarnail Singh Thakur,Amanda G. Thrift,Roman Topor-Madry,Thomas Truelsen,Stefanos Tyrovolas,Kingsley N. Ukwaja,Olalekan A. Uthman,Tommi Vasankari,Vasiliy Victorovich Vlassov,Stein Emil Vollset,Tolassa Wakayo,David A Watkins,Robert G. Weintraub,Andrea Werdecker,Ronny Westerman,Charles Shey Wiysonge,Charles D.A. Wolfe,Abdulhalik Workicho,Gelin Xu,Yuichiro Yano,Paul S. F. Yip,Naohiro Yonemoto,Mustafa Z. Younis,Chuanhua Yu,Theo Vos,Mohsen Naghavi,Christopher J L Murray +173 more
TL;DR: The GBD (Global Burden of Disease) 2015 study integrated data on disease incidence, prevalence, and mortality to produce consistent, up-to-date estimates for cardiovascular burden, finding that CVDs remain a major cause of health loss for all regions of the world.
Journal ArticleDOI
Strategies for Multivessel Revascularization in Patients with Diabetes
Michael E. Farkouh,Michael J. Domanski,Lynn A. Sleeper,Flora S. Siami,George Dangas,Michael J. Mack,David J. Cohen,Yves Rosenberg,Scott D. Solomon,Akshay S. Desai,Bernard J. Gersh,Elizabeth A. Magnuson,Alexandra J. Lansky,Robin Boineau,Jesse Weinberger,Krishnan Ramanathan,J. Eduardo Sousa,Jamie Rankin,Balram Bhargava,John B. Buse,Whady Hueb,Craig R. Smith,Victoria Muratov,Sameer Bansilal,Spencer B. King,Michel E. Bertrand,Valentin Fuster +26 more
TL;DR: For patients with diabetes and advanced coronary artery disease, CABG was superior to PCI in that it significantly reduced rates of death and myocardial infarction, with a higher rate of stroke.
Journal ArticleDOI
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
Steen Dalby Kristensen,Juhani Knuuti,Antti Saraste,Stefan D. Anker,Hans Erik Bøtker,Stefan De Hert,Ian Ford,José Ramón González-Juanatey,Bulent Gorenek,Guy R. Heyndrickx,Andreas Hoeft,Kurt Huber,Bernard Iung,Keld Kjeldsen,Dan Longrois,Thomas F. Lüscher,Luc Pierard,Stuart J. Pocock,Susanna Price,Marco Roffi,Per Anton Sirnes,Miguel Sousa-Uva,Vasilis Voudris,Christian Funck-Brentano +23 more
TL;DR: Clinicians will find the recommendations in these revised CPGs useful in their daily work and can be reassured that the recommendations have been vetted thoroughly by the most rigorous scientific process, so that cardiovascular clinicians worldwide may deliver optimal, standardized care.
Journal ArticleDOI
Initial invasive or conservative strategy for stable coronary disease.
David J. Maron,Judith S. Hochman,Harmony R. Reynolds,Sripal Bangalore,Sean M. O'Brien,William E. Boden,Bernard R. Chaitman,Roxy Senior,Roxy Senior,Jose Lopez-Sendon,Karen P. Alexander,Renato D. Lopes,Leslee J. Shaw,Jeffrey S. Berger,Jonathan D. Newman,Mandeep S. Sidhu,Shaun G. Goodman,Witold Rużyłło,Gilbert Gosselin,Aldo P. Maggioni,Harvey D. White,Balram Bhargava,James K. Min,G.B. John Mancini,Daniel S. Berman,Michael H. Picard,Raymond Y. Kwong,Ziad A. Ali,Ziad A. Ali,Daniel B. Mark,John A. Spertus,Mangalath Narayanan Krishnan,Ahmed Elghamaz,Nagaraja Moorthy,Whady Hueb,Marcin Demkow,Kreton Mavromatis,Kreton Mavromatis,Olga L. Bockeria,Jesús Peteiro,Todd D. Miller,Hanna Szwed,Rolf Doerr,Matyas Keltai,Joseph B. Selvanayagam,P. Gabriel Steg,Claes Held,Claes Held,Shun Kohsaka,Stavroula Mavromichalis,Ruth Kirby,Neal Jeffries,Frank E. Harrell,Frank W. Rockhold,Samuel Broderick,T. Bruce Ferguson,David O. Williams,Robert A. Harrington,Gregg W. Stone,Yves Rosenberg +59 more
TL;DR: Evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years is not found.
Journal ArticleDOI
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Sean van Diepen,Jason N. Katz,Nancy M. Albert,Timothy D. Henry,Alice K. Jacobs,Navin K. Kapur,Ahmet Kilic,Venu Menon,E. Magnus Ohman,Nancy K. Sweitzer,Holger Thiele,Jeffrey B. Washam,Mauricio G. Cohen +12 more
TL;DR: The epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock are summarized; contemporary best medical, surgical, mechanical circulatory support, and palliative care practices are reviewed; the development of regionalized systems of care is advocated; and future research priorities are outlined.
References
More filters
Journal ArticleDOI
Third universal definition of myocardial infarction
Kristian Thygesen,Joseph S. Alpert,Allan S. Jaffe,Maarten L. Simoons,Bernard R. Chaitman,Harvey D. White +5 more
TL;DR: Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …
Journal ArticleDOI
Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions
Donald E. Cutlip,Stephan Windecker,Roxana Mehran,Ashley B Boam,David J. Cohen,Gerrit-Anne van Es,P. Gabriel Steg,Marie-Angèle Morel,Laura Mauri,Pascal Vranckx,Eugene P. McFadden,Alexandra J. Lansky,Martial Hamon,Mitchell W. Krucoff,Patrick W. Serruys +14 more
TL;DR: Criteria for assessment of death, myocardial infarction, repeat revascularization, and stent thrombosis were developed and provide consistency across studies that can facilitate the evaluation of safety and effectiveness of these devices.
Journal ArticleDOI
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
Elliott M. Antman,Jean-Pierre Bassand,Werner Klein,Magnus Ohman,José Luis López Sendón,Lars Rydén,Maarten L. Simoons,Michal Tendera +7 more
TL;DR: In this paper, the authors defined the definition of MI and established the following criteria for acute, evolving or recent MI: 1) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Qwaves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d) coronary artery intervention (e.g., coronary ang
Journal ArticleDOI
Universal definition of myocardial infarction
TL;DR: The past history, and likely future of this important topic has been/will remain more “evolution” than “big-bang”, and the current redefinition was flawed at inception owing to a fundamental problem with the troponin assays available at that time.
Journal ArticleDOI
Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
Joseph S. Alpert,Elliott M. Antman,Fred S. Apple,Paul W. Armstrong,J. P. Bassand,A. B. De Luna,George A. Beller,Günter Breithardt,Bernard R. Chaitman,Peter Clemmensen,Erling Falk,Michael C. Fishbein,Marcello Galvani,A Jr Garson,Cindy L. Grines,Christian W. Hamm,B. Nauheim,Uta C. Hoppe,Allan S. Jaffe,Hugo A. Katus,J. Kjeksus,Werner Klein,P. Klootwijk,C. Lenfant,Daniel Levy,R. I. Levy,Russell V. Luepker,F. Marcus,Ulf Näslund,Magnus Ohman,O. Pahlm,P. A. Poole-Wilson,R. Popp,Kalevi Pyörälä,Jan Ravkilde,N. Rehnquist,W. Roberts,Robert Roberts,J. Roelandt,Lars Rydén,Susana Sans,M. L. Simoons,Kristian Thygesen,Hugh Tunstall-Pedoe,Richard Underwood,Barry F. Uretsky,F. Van de Werf,L. M. Voipio-Pulkki,Galen S. Wagner,Lars Wallentin,William Wijns,David R. Wood +51 more
TL;DR: Biochemical markers of myocardial necrosis may have normalized, depending on the length of time that has passed since the infarct developed, and one of the following criteria satisfies the diagnosis for established MI: development of new pathologic Q waves on serial ECGs.
Related Papers (5)
Non-Q-wave myocardial infarction: comprehensive analysis of electrocardiogram, pathophysiology, and therapeutics.
Manuel Velasco,Edward Rojas +1 more